PRECIOUS NEWS | ISSUE 7 | 03/2018
 
 
Link to website
 
 
PRECIOUS NEWS | ISSUE 7 | 03/2018
 
 

Content

Trial progress

PRECIOUS has started patient recruitment in all 9 countries!

The Institute of Psychiatry and Neurology, Warsaw (Poland) and Ioannina University Hospital (Greece) have recruited their first patient. Universitätsklinikum Heidelberg (Germany) had their Site Initiating Visit (SIV) recently and will start recruiting patients. 

Top 5 recruiting centers overall*

1. Haaglanden Medisch Centrum, NL (13 patients)

2. Nottingham University Hospital Trust and Kings College Hospital, UK (both 7 patients)

3. ASST di Mantova, IT and University Medical Center Hamburg Eppendorf, DE (both 6 patients)

 

* With the exception of UMC Utrecht, NL (45 patients)

PRECIOUS on Tour

During the first three days of March, PRECIOUS travelled south, to the Hellenic Stroke Organization Conference (www.stroke.gr) in Athens. During this event, over 350 delegates and the international faculty members had the opportunity to interact at the PRECIOUS booth, receive information and printed material about PRECIOUS, and discuss the potential impact of the trial on stroke management and outcome. We thank the team of Larissa Hospital (Greece) for organizing the PRECIOUS booth!

 


Total number of patients included: 141

 

 

 

Instructions regarding SAE reporting

  1. To report an SAE, please complete the form in the online eCRF (www.researchonline.org). A completed form can be printed out, and please send a signed version by email/fax to the Safety Desk.
  2. If new information regarding the SAE becomes available, please edit the completed SAE form in the eCRF. The edited form can be printed out and signed. Please write per hand “follow-up” on the form. If the outcome of the SAE changes, please select the worst outcome.

 

 

 

 

Contact

Coordinator

University Medical Center Utrecht, The Netherlands
Dr. Bart van der Worp

Project Management

ARTTIC, Germany
Sophie Rau

 

Follow us on Twitter!

 
 
PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.
The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.
Copyright | Imprint PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.<br>The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.
 

If you no longer wish to receive our newsletter please click here to unsubscribe.

Having trouble viewing this email? Click here to view it in your browser.